This is a paid press release. Contact the press release distributor directly with any inquiries.

Medtronic to announce financial results for its third quarter of fiscal year 2026

PR Newswire

Thu, February 12, 2026 at 3:56 AM GMT+9 2 min read

In this article:

MDT

-0.98%

GALWAY, Ireland, Feb. 11, 2026 /PRNewswire/ – Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, February 17, 2026, for its third quarter of fiscal year 2026, which ended on Friday, January 23, 2026.

A news release containing summary financial information will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at 

A video webcast to discuss results will begin at 7:00 a.m. CST and can be accessed at 

Within 24 hours of the video webcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at .

**About Medtronic

**Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:

Justin Paquette
Public Relations
+1-612-271-7935

Ingrid Goldberg 
Investor Relations 
+1-763-505-2696

(PRNewsfoto/Medtronic plc)

Cision

View original content to download multimedia:

Condiciones y Política de privacidad

Privacy Dashboard

More Info